JNJ

FDA spurns J&J’s troubled rheumatoid arthritis drug sirukumab
FDA spurns J&J’s troubled rheumatoid arthritis drug sirukumab
Endpoints
FDA
JNJ
rheumatoid arthritis
sirukumab
Flag link:
J&J Alerted to Risk of Asbestos in Talc in '70s, Files Show
J&J Alerted to Risk of Asbestos in Talc in '70s, Files Show
Newsmax
JNJ
Flag link:
Johnson & Johnson challenges $417M talc verdict, its largest defeat yet
Johnson & Johnson challenges $417M talc verdict, its largest defeat yet
Fierce Pharma
JNJ
Flag link:
With help from J&J, upstart Provention lands rights to two mid-stage IBD drugs and shoots for PhII
With help from J&J, upstart Provention lands rights to two mid-stage IBD drugs and shoots for PhII
Endpoints
JNJ
Provention Bio
IBD
inflammatory bowel disease
PRV-6527
Crohn's Disease
PRV-300
ulcerative colitis
Flag link:
This squabble between two big drugmakers could have major implications for the U.S. health care system
This squabble between two big drugmakers could have major implications for the U.S. health care system
Marketwatch
JNJ
Pfizer
antitrust
biosimilars
Remicade
Inflectra
Flag link:
Pfizer files US lawsuit against Johnson & Johnson over "anticompetitive" practices related to Remicade biosimilar
Pfizer files US lawsuit against Johnson & Johnson over "anticompetitive" practices related to Remicade biosimilar
First Word Pharma
Pfizer
JNJ
Janssen
Remicade
biosimilars
Inflectra
Flag link:
J&J, BARDA join forces to prep for pandemic flu, inking deal for vaccine and drug R&D
J&J, BARDA join forces to prep for pandemic flu, inking deal for vaccine and drug R&D
Fierce Pharma
JNJ
BARDA
pandemic flu
vaccines
R&D
Flag link:
10 Rock-Solid Reasons Johnson & Johnson's Near-Term Future Looks Bright
10 Rock-Solid Reasons Johnson & Johnson's Near-Term Future Looks Bright
Motley Fool
JNJ
Remicade
Stelara
drug pricing
Imbruvica
Xarelto
Darzalex
devices
consumer health
Flag link:
Why Amgen, Lilly, J&J Are Interested In These Small Biotechs
Why Amgen, Lilly, J&J Are Interested In These Small Biotechs
Investors Business Daily
Amgen
Eli Lilly
JNJ
Exelixis
biotech
Theravance
Bavarian Nordic
Agios
Biohaven Pharmaceuticals
Progenics
Flag link:
J&J moves away from hep C due to rival drugmakers' cures
J&J moves away from hep C due to rival drugmakers' cures
BioPharma Dive
JNJ
hepatitis C
JNJ-4178
R&D
hepatitis B
Flag link:
GSK, JnJ and Sanofi: potential buyers of Merck KGaA’s Consumer Health business
GSK, JnJ and Sanofi: potential buyers of Merck KGaA’s Consumer Health business
GoInPharma
GSK
JNJ
Sanofi
Merck KGaA
consumer health
M&A
Flag link:
AbbVie and Pfizer hover at top, J&J Stelara surges in August TV pharma ad spend
AbbVie and Pfizer hover at top, J&J Stelara surges in August TV pharma ad spend
Fierce Pharma
AbbVie
Pfizer
JNJ
drug ads
television ads
Flag link:
J&J scraps a multibillion-dollar hepatitis C program after rivals divvy up the market
J&J scraps a multibillion-dollar hepatitis C program after rivals divvy up the market
Endpoints
JNJ
Achillion
hepatitis C
odalasvir
ACH-3102
Flag link:
J&J’s Ethicon hit with $57m verdict in pelvic mesh case
J&J’s Ethicon hit with $57m verdict in pelvic mesh case
Mass Device
JNJ
Ethicon
pelvic mesh
devices
Flag link:
Takeda, Johnson & Johnson and more join Clara Health's Boston-based patient empowerment push
Takeda, Johnson & Johnson and more join Clara Health's Boston-based patient empowerment push
Fierce Pharma
Takeda
JNJ
Clara Health
Amylyx Pharmaceuticals
patients
Boston
Flag link:
Texas Judge delays J&J Pinnacle hip implant bellwether trial
Texas Judge delays J&J Pinnacle hip implant bellwether trial
Mass Device
JNJ
Pinnacle Hip
hip implants
devices
Texas
DePuy Ortho
Flag link:
Neurotoxicity kills a CAR-T rival pushed by J&J, MacroGenics in $700M deal
Neurotoxicity kills a CAR-T rival pushed by J&J, MacroGenics in $700M deal
Endpoints
JNJ
CAR-T
Macrogenics
MGD011
Flag link:
Boston Scientific, J&J win Pentagon award for supporting employed service members
Boston Scientific, J&J win Pentagon award for supporting employed service members
Mass Device
Boston Scientific
JNJ
devices
military
Flag link:
J&J Investors Should Ignore The Noise Of Cancer Lawsuits For Now
J&J Investors Should Ignore The Noise Of Cancer Lawsuits For Now
Seeking Alpha
JNJ
ovarian cancer
Flag link:
Best Pharma Stocks Based on R&D Spending
Best Pharma Stocks Based on R&D Spending
Motley Fool
R&D
pharma stocks
Roche
Novartis
Pfizer
JNJ
Merck
Flag link: